semaglutide samples While many patients are seeing life-changing results with GLP-1 medications, doctors say the medications can also come with risks if they are not dosed properly. Read the full story in the link Semaglutide for weight loss |

The latest research and trials on the effect of GLP-1RAs in the eye were searched until April 2025, including thorough cellular studies, animal studies, and clinical observation surrounding glaucoma, diabetic retinopathy, and other ocular diseases

In 2021, Wegovy, a slightly different formulation of the same drug, was approved for weight loss for people with obesity or people who have health problems related to being overweight

In adults with Type 2 diabetes who have existing heart disease or multiple heart risk factors, Farxiga can reduce the risk of hospital visits due to heart failure

Supplementary Video 2 Partial unbinding and binding simulation of Ex4